NSEShareholders meeting1h ago · 25 Sept 2026, 06:21 pm
Shareholders meeting
Bal Pharma Limited · BALPHARMA
✦ AI Summaryshareholders_meeting
Bal Pharma Limited has submitted the Exchange a copy of the Scrutinizer's report of the 39th Annual General Meeting held on September 24, 2026, and informed the Exchange regarding voting results.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bal Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.
Attachments (1)
📄pdf
Download →
BALPHARMA1_25092026182050_Result_Final.pdf
View document text
To To Date: September 25, 2026
Listing Compliance Department BSE Limited
National Stock Exchange of India Limited, 1st Floor, New Trading
Exchange Plaza, 5th Floor, Plot No. C/2, G Ring,
Block, Rotunda Building, P.J.
Bandra Kurla Complex, Bandra (E), Towers,
Mumbai-400051 Dalal Street,
Mumbai – 400001
Symbol: BALPHARMA Scrip Code: 524824
Sub: Voting Results and Scrutinizer’s Report of the 39th Annual General Meeting (AGM):
Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 and Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies
(Management and Administration) Rules, 2014, as amended from time to time, we hereby submit
the following documents in respect of the 39th Annual General Meeting (“AGM”) of the Company
held on September 24, 2026 at 11:30 A.M. through Video Conferencing/Other Audio-Visual Means
(“VC/OAVM”):
1. Consolidated Voting Results of the resolutions passed at the 39th AGM, as declared by
Mr. Shailesh Siroya, Managing Director of the Company; and
2. Scrutinizer’s Report submitted by Mr. Parameshwar Bhat, Practicing Company Secretary
(Membership No. 11004), on the resolutions set forth in the AGM Notice dated August 12,
2026 convening the 39th AGM.
The aforesaid Voting Results and Scrutinizer’s Report are also being made available on the website
of the Company at www.balpharma.com.
You are requested to kindly take the above submission on record.
Thanking You.
For Bal Pharma Limited
Shreepada ML
Company Secretary and Compliance officer
ICSI M No : A66681
Enclosure: As above
DECLARATION OF VOTING RESULTS OF THE RESOLUTIONS PASSED THROUGH REMOTE
E-VOTING AND E-VOTING DURING THE 39TH ANNUAL GENERAL MEETING OF BAL
PHARMA LIMITED HELD ON 24TH SEPTEMBER, 2026 AT 11:30 A.M. THROUGH VIDEO
CONFERENCING / OTHER AUDIO-VISUAL MEANS (“VC/OAVM”)
Dear Members,
We hereby declare the consolidated voting results in respect of the resolutions considered and
passed at the 39th Annual General Meeting (“AGM”) of Bal Pharma Limited (“the Company”),
held on 24th September, 2026 at 11:30 A.M. through Video Conferencing / Other Audio-Visual
Means (“VC/OAVM”), based on the Consolidated Scrutinizer’s Report submitted by Mr.
Parameshwar Bhat, Practicing Company Secretary (M. No. 11004).
The Company had provided its members with the facility to cast their votes through remote e-
voting from 21st September, 2026 at 9:00 A.M. (IST) to 23rd September, 2026 at 5:00 P.M. (IST).
The Company also provided the facility of e-voting during the AGM to those Members who were
present at the AGM through VC/OAVM and had not cast their votes through remote e-voting.
The Board of Directors of the Company had appointed Mr. Parameshwar Bhat, Practicing
Company Secretary (M. No. 11004), as the Scrutinizer to scrutinize the remote e-voting process
and the e-voting conducted during the AGM in a fair and transparent manner.
The Scrutinizer submitted his Consolidated Report dated 24th September, 2026, containing the
results of the remote e-voting and e-voting conducted during the AGM.
Based on the Consolidated Scrutinizer’s Report, the voting results in respect of the resolutions
considered at the 39th AGM are as follows:
Resolution %age of
%age of
Srl Type votes
Particulars votes cast
No. (Ordinary/ cast in
in favour
Special) against
1 To receive, consider and adopt the Audited
Standalone and Consolidated Financial Ordinary
Statements of the Company for the financial year Resolution
ended March 31, 2026, together with the Reports 100 0*
of the Board of Directors and the Auditors
thereon.
Ordinary
To declare dividend of Rs. 1.20 per equity share
2 Resolution 100 0*
of Rs. 10/- each for the Financial Year 2025-26.
3 To re-appoint Mr. Ravindra Kumar Kothari (DIN:
03418320), who retires by rotation, as a Director Ordinary
99.75 0.25
of the Company. Resolution
4 To ratify the remuneration payable to the Cost
Ordinary
Auditors for the Financial Year 2026-27. 100 0*
Resolution
5 To renew the contract with M/s. Desa Marketing
Ordinary
International. 99.44 0.56
Resolution
6 To approve the change in designation of Mr.
Ravindra Kumar Kothari (DIN: 03418320) from Special
99.75 0.25
Non-Executive Director to Whole-Time Director. Resolution
7 To approve the change in designation of Mr.
Virupakshaya Himesh (DIN: 08554422) from Special
100 0*
Whole-Time Director to Non-Executive Director. Resolution
* Negligible
Based on the Consolidated Scrutinizer’s Report, all the aforesaid resolutions were duly passed
by the Members at the 39th Annual General Meeting with the requisite majority.
The detailed voting results, as required under the applicable provisions of the Companies Act,
2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
enclosed herewith.
Thanking you.
Yours faithfully,
For Bal Pharma Limited
Shailesh Siroya
Managing Director
DIN: 00048109
Enclosure: As above
PARAMESHWAR G. BHAT
# 496/4, II Floor, 10th Cross
B.Com., LLB, ML, MBA, FCS
Near Bashyam Circle, Sadashivanagar,
Bangalore - 560 080
Company Secretary
Tel : +91 80 23610847
Telefax : +91 80 41231106
e-mail ; parameshwar@vijkt.in
parameshwar.g.bhat@gmail.com
SCRUTINIZER’S REPORT
[Pursuant to Sections 108 & 109 of the Companies Act, 2013 and the Companies
(Management & Administration) Rules, 2014]
{Private & Confidential}
{Strictly to the addressee only}
Mr. Shailesh Siroya
Managing Director & Chairman of the 39" Annual General Meeting
Bal Pharma Limited
Bengaluru
Dear Sir,
|, Parameshwar G Bhat, Practicing Company Secretary (Membership No. FCS 8860, CP
No. 11004), having office at # 496/4, 2™ Floor, 10” Cross, Near Bashyam Circle,
Sadashivanagar, Bengaluru - 560 080, duly appointed as Scrutinizer by Bal Pharma
Limited (‘the Company’) for the purpose of scrutinizing the e-voting prior to the Annual
General Meeting (‘remote e-voting’) and electronic voting (‘e-voting) at the 39° Annual
General Meeting (AGM) held on Thursday, 24! day of September, 2026 at 11:30 A.M
(held through Video Conferencing (‘VC’VOther Audio Visual Means (OAVM’}), pursuant
to Sections 108 and 109 of the Companies Act, 2013 (the Act), read with Rules 20 and
21 of the Companies (Management & Administration) Rules, 2014 (the Rules) as
amended from time to time and the provisions of Regulation 44 of Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015 (‘the Listing Regulations’), hereby furnish my Report to you.
The notice dated 12" day of August, 2026 as confirmed by the Company was sent to the
Shareholders on 26' day of August, 2026 in respect of the below mentioned resolutions
passed at the AGM of the Company, in compliance with the Ministry of Corporate Affairs
(MCA) General Circulars namely Circular No.19/2021 dated December 8, 2021 read with
Circular No.14/2020 dated April 8, 2020, Circular No.17/2020 dated April 13, 2020,
Circular No. 20/2020 dated May 5, 2020, Circular No. 02/2021 dated January 13, 2021,
Circular No. 03/2022 dated May 5, 2022, General Circular No. 11/2022 dated December
28, 2022, General Circular No. 09/2024 dated September 19, 2024 and read with other
8860
P-11004
relevant circulars issued in this regard the latest being General Circular No. 03/2025
dated September 22, 2025 (collectively referred to as "MCA Circulars") and SEB|
Circulars dated 12" May, 2020, 15tn January, 2021,13! May, 2022, 25'" September, 2023
and 3 October, 2024 issued by the Securities and Exchange Board of India (collectively
referred to as ‘SEBI Circulars’) permitted the holding of the Annual General Meeting
(‘AGM’) through VC/OAVM, without the physical presence of the Members.
The Management of the Company is responsible to ensure compliance of the
requirements of the Companies Act, 2013 and Rules made there under relating to voting
through remote e-voting and e-voting at the Annual General Meeting for the resolutions
proposed in the Notice of 39" Annual General Meeting. My responsibility as a Scrutinizer
is to en
[Showing first 8,000 characters — download PDF for full document]